Barclays Increases Union Pacific Price Target to $285
Barclays maintained its Overweight rating for Union Pacific Corporation (NYSE:UNP) on December 16, 2025, while increasing its price target from $270 to $285. The adjustment follows a period of increased institutional investment and reflects a positive outlook on the railroad transportation provider.
Capital Asset Advisory Services LLC expanded its position in the company by 16.6% during the most recent quarter. The firm currently holds 14,736 shares with an estimated value of $3.48 million USD. Other institutional adjustments include Park National Corp OH, which raised its stake by 0.9% to 12,159 shares valued at $2.87 million USD, and Jacobs and Co. CA, which increased its holdings by 2.7%.
On the day of the announcement, Union Pacific shares traded at $240.48, representing a daily increase of 0.2% or $0.53. The stock reached an intraday high of $241.17 and a low of $238.14. Over the preceding 52-week period, the equity has fluctuated between a low of $204.66 and a high of $256.84.
Union Pacific maintains a market capitalization of approximately $142.63 billion USD. Trading volume for the session reached 2,185,127 shares. Further details regarding the company are available through the UNP and the UNP.
The company continues to provide freight transportation services across the United States. For more information on its long-term objectives and fiscal status, see the UNP and UNP reports.
Union Pacific Corporation (UNP) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.